{
  "denotations": [
    {
      "id": "T1",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 28,
        "end": 33
      }
    },
    {
      "id": "T3",
      "obj": "Chemical",
      "span": {
        "begin": 77,
        "end": 80
      }
    },
    {
      "id": "T6",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 179,
        "end": 184
      }
    },
    {
      "id": "T8",
      "obj": "Chemical",
      "span": {
        "begin": 213,
        "end": 216
      }
    },
    {
      "id": "T10",
      "obj": "Disease",
      "span": {
        "begin": 263,
        "end": 286
      }
    },
    {
      "id": "T11",
      "obj": "Disease",
      "span": {
        "begin": 289,
        "end": 292
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "24597466_4",
  "text": "RESULTS : Patients carrying HLA-B * 15:02 are at strongly increased risk for CBZ -induced Stevens-Johnson syndrome / toxic epidermal necrolysis ( SJS / TEN ) in populations where HLA-B * 15:02 is common , but not CBZ -induced hypersensitivity syndrome ( HSS ) or maculopapular exanthema ( MPE ) ."
}
